Investors are increasingly betting that “China is back” as the economy rebounds from years of deflation, helped by strong manufacturing, ex...

American business leaders are heading to China for a summit with President Xi Jinping. They aim to resolve ongoing business challenges and ...

India’s cancer treatment landscape is seeing a shift as lower-cost immunotherapy drugs developed in China and marketed through Indian partn...

Happy Thursday! VCs are doubling down on India’s deeptech, with early-stage bets leading the charge. This and more in today’s ETtech Mornin...

India's obesity treatment market is set for a major shift by year-end. A wave of oral GLP1 weight-loss pills, including those from China, w...

China's state-of-the-art factories reflect its commitment to innovation, backed by robust research and development initiatives. This enviro...

India's drug companies face a tough race in the global biologics market. China is quickly becoming a leader in biotech supply chains. India...

American biggies are joining hands with Chinese companies. AbbVie signed a deal with Simcere Zaiming for a multiple myeloma treatment. Astr...

Chinese biotech company Akeso developed a lung cancer drug Ivonescimab, which outperformed Merck's Keytruda in trials. This breakthrough si...

The US government is concerned that certain Chinese biotech companies are contributing technology or research and development for use by Ch...

The fertilizer issue has triggered farmer protests due to non-availability of chemical fertilizers. President Gotabaya Rajapaksa in May ord...

In a letter to the Bangladesh government on September 22, Beijing headquartered Sinovac Biotech said the phase 3 trials of the vaccine they...

Last week, the U.S. Justice Department made public an indictment of two Chinese nationals accused of spying on the United States, including...

A lobby group of biotech drug companies in India has raised concerns about the approval of Cipla's first biosimilar drug Etanercept.

The global pecking order of blockbusters may soon be heading for a major upheaval with biotech drugs toppling the present market leaders.

Drug maker Cipla on Tuesday said it will invest USD 65 million (nearly Rs 300 crore) over the next three years with a Chinese joint venture...

Consumers in Asia, especially India, China, Philippines are ready to accept the benefits of biotechnology derived foods, according to a con...